India  

First batch of DRDO's anti-Covid drug to be released on Monday

IndiaTimes Sunday, 16 May 2021
0
shares
ShareTweetSavePostSend
 
Video Credit: Oneindia - Published
News video: Covid-19: Rajnath Singh released first batch of anti-covid drug 2-DG | Oneindia News

Covid-19: Rajnath Singh released first batch of anti-covid drug 2-DG | Oneindia News 02:34

The first batch of anti-Covid oral drug 2-DG, developed by the DRDO, was released on Monday by Defence Minister Rajnath Singh and Health Minister Harsh Vardhan. Even as the country is reeling under vaccine shortage and growing Covid cases, vaccines worth lakhs were destroyed in a fire at a godown in...

💡 newsR Knowledge: Other News Mentions

Defence Research and Development Organisation Defence Research and Development Organisation Government agency in India

DRDO invites EoI to transfer technology of 2-DG drug for bulk production

The Defence Research and Development Organisation (DRDO), which developed 2-Deoxy-D- Glucose (2-DG), a drug used for treatment of Covid-19 patients, has called..
IndiaTimes

Contrary to vow, DRDO drug has steep price tag of Rs 990 a sachet

Contrary to promises that the indigenously developed Covid-19 drug 2-deoxy-D-glucose (2-DG) would be priced affordably to ensure it reaches as many patients as..
IndiaTimes
DRDO's new Covid-19 drug 2-DG: All you need to know, how effective is it? | Oneindia News [Video]

DRDO's new Covid-19 drug 2-DG: All you need to know, how effective is it? | Oneindia News

Institute of Nuclear Medicine and Allied Sciences and DRDO scientists conducted experiments with the help of the Center for Cellular and Molecular Biology and found that this molecule works effectively against Covid. Three phases of trials were conducted to ensure its efficacy. #2DG #Oraldrug #DRDO #Covid19 #INMAS

Credit: Oneindia    Duration: 01:24Published

COVID-19 COVID-19 Disease caused by severe acute respiratory syndrome coronavirus 2

'He has been brave': UK's longest-known COVID patient dies after withdrawing from treatment

The UK's longest-known coronavirus patient has died after choosing to withdraw from treatment, his wife has confirmed.
Sky News
CNN Heroes: Helping the homeless through the pandemic [Video]

CNN Heroes: Helping the homeless through the pandemic

The Covid-19 could not stop CNN Hero Shirley Raines from serving the homeless on Skid Row, but it did force her to make some changes.

Credit: Bleacher Report AOL    Duration: 01:33Published

Cinderella not going to the ball as Lloyd Webber withdraws musical from live events COVID pilot

Andrew Lloyd Webber has pulled his latest musical out of a government pilot scheme for live events because theatre had been treated as "an afterthought and..
Sky News
Slavitt: Covid-19 a manageable challenge for kids [Video]

Slavitt: Covid-19 a manageable challenge for kids

Andy Slavitt, former White House Senior Adviser for Covid and author of “Preventable”, talks about the Delta variant, vaccinations and Obamacare.

Credit: Bleacher Report AOL    Duration: 14:31Published

You Might Like


Related videos from verified sources

FDA Approves First New Alzheimer’s Drug In 18 Years [Video]

FDA Approves First New Alzheimer’s Drug In 18 Years

The FDA on Monday approved the first new drug for Alzheimer’s patients in 18 years despite an advisory panel voting against it. CBS2's Dr. Max Gomez reports.

Credit: CBS 2 New York     Duration: 02:08Published
FDA Approves Alzheimer’s Disease Drug [Video]

FDA Approves Alzheimer’s Disease Drug

Government health officials on Monday approved the first new drug for Alzheimer’s disease in nearly 20 years. KDKA's Amy Wadas has more.

Credit: KDKA CBS 2 Pittsburgh     Duration: 02:26Published
FDA Approves Biogen's Aducanumab As First New Alzheimer's Drug In Nearly 20 Years [Video]

FDA Approves Biogen's Aducanumab As First New Alzheimer's Drug In Nearly 20 Years

The FDA approved the first new drug for Alzheimer’s disease in nearly 20 years Monday, even though the decision to greenlight Biogen’s new drug has been fraught with controversy. WBZ-TV's Mallika..

Credit: WBZ CBS Boston     Duration: 02:26Published